High-yield points
- Children usually present with hemorrhage (about 60–80%), and AVMs are the leading cause of spontaneous hemorrhage in children .
- Annual hemorrhage risk is about 2%, similar to adults once you adjust for presentation, but children have decades of exposure .
- ARUBA was adults only. Most pediatric centers aim for cure when it is safe .
- Grade with both scales: Spetzler–Martin plus the supplementary grade. Young age favors surgery .
- Surgery cures low-grade AVMs. SRS obliterates about 63% after a latency with ongoing bleeding risk. Embolization is an adjunct .
- Recurrence is about 11% in children: keep imaging (including angiography) for years after cure .
Landmark papers
- ARUBA (Mohr et al., Lancet 2014): adults 18 and older with unruptured AVMs. Medical management alone beat intervention for death or stroke at 33 months (10.1% vs 30.7%); children were not included .
- KRAS mutations (Nikolaev et al., N Engl J Med 2018): somatic activating KRAS mutations were found in AVM tissue from 45 of 72 patients and in none of their blood samples .
- Children vs adults (Fullerton et al., Stroke 2005): after adjusting for presentation, children's subsequent hemorrhage rate was lower (HR 0.10) .
Brain AVMs are the leading cause of spontaneous intracranial hemorrhage in children . Compared with adults, children more often present with rupture and are more likely to recur after apparent cure. Because they have decades of risk ahead, cure (complete obliteration) is the goal whenever it can be achieved safely.
Biology and presentation
- Cause: somatic activating KRAS mutations were found in AVM tissue from 45 of 72 patients and in none of their blood samples. They drive MAPK–ERK signaling in endothelial cells .
- Presentation: hemorrhage is the most common presentation in children .
- Large cohort (189 children): 63% were ruptured .
- Single center (50 children): 40 presented as emergencies with hemorrhage, and 4% died of acute hemorrhage .
- Unruptured AVMs: in 76 children, 86.8% had headaches, seizures or deficits, and 13.1% were incidental. Incidental AVMs were smaller and less often deep-draining .
- Rupture severity: the Ruptured AVM Grading Scale (RAGS) predicted functional outcome in 81 children better than Hunt–Hess or GCS (AUROC about 0.81) .
Natural history
- Hemorrhage risk is not higher in children once you account for how they present:
- The average annual rate of subsequent hemorrhage was 2.0% in children vs 2.2% in adults.
- Children presented with rupture more often. After adjusting for that, their subsequent hemorrhage rate was lower (HR 0.10) .
- Lifetime risk: even at about 2% a year, a child has decades of exposure. That is why pediatric teams treat most AVMs that can be treated safely .
- ARUBA (adults 18 and older, unruptured): medical management alone beat intervention for death or stroke at 33 months (10.1% vs 30.7%) . It did not include children, and its short follow-up limits its application to pediatric lifetimes.
Grading
- Spetzler–Martin grade: scores nidus size, venous drainage pattern (superficial vs deep) and the eloquence of adjacent brain into grades I–V, plus VI for inoperable lesions. It predicts surgical morbidity .
- Usual points: size under 3 cm = 1, 3–6 cm = 2 and over 6 cm = 3; eloquent location = 1; deep venous drainage = 1.
- Supplementary (Lawton–Young) grade: adds patient age, hemorrhagic presentation, nidal diffuseness and deep perforating artery supply. Combined with Spetzler–Martin, it predicts surgical outcome better than Spetzler–Martin alone (ROC area 0.73 vs 0.65) .
- Calculator: the AVM Grading Calculator in this section scores both grades interactively.
- Young age and prior rupture both lower surgical risk on this scale, which favors surgery in children .
Treatment
- Multimodal, team-based treatment in 189 children:
- Obliteration in 73.4% of grade I–III and 45.2% of grade IV–V AVMs.
- 1 periprocedural stroke (0.5%) and 1 treatment-related death.
- Post-treatment hemorrhage of about 2% per person-year .
- Microsurgery: obliteration of 81–100% in selected pediatric series (mean about 93%). It is the first choice for accessible, low-grade lesions .
- Stereotactic radiosurgery (SRS):
- Pooled pediatric data (3,425 patients): obliteration 63% with at least 1 year of follow-up, with no difference between Gamma Knife and LINAC. Prior hemorrhage and prior procedures were associated with higher obliteration .
- Latency: about one-quarter of obliterated AVMs closed within 24 months. Female sex, smaller volume, a deep location and higher dose predicted early obliteration .
- Hemorrhage before obliteration occurred in about 1.1–3.2% across series .
- Infratentorial AVMs responded similarly to supratentorial ones .
- Large ruptured AVMs (volume-staged SRS, 42 children): obliteration was 37% at 5 years and 56% at 10 years, but the 5-year post-SRS hemorrhage rate was 19% .
- Embolization: mainly an adjunct before surgery or SRS.
- In pediatric ruptured AVMs, recurrence was more frequent when embolization was the final treatment (60% of recurrences vs 13.3% of non-recurrences) .
- In one series, 2 of 3 post-treatment hemorrhages followed embolization .
Recurrence after "cure": image long term
- Recurrence is a pediatric problem:
- Pooled recurrence after obliteration was 10.9%. It was more frequent with younger age and infratentorial location, and after embolization as the final treatment .
- Across cohorts, reported recurrence ranged from under 1% to 29%, often years after obliteration .
- Surveillance catches it early:
- With follow-up imaging, recurrences were found earlier (mean 3.6 vs 8.9 years).
- Ruptured recurrences were far less common with surveillance (13% vs 57%) .
- Recurrence has been documented 54 months after angiographic cure, so dedicated surveillance angiography is recommended .
Related topics
- AVM Grading Calculator: interactive Spetzler-Martin and supplemented grades.
- Cerebral Proliferative Angiopathy: a diffuse AVM mimic.
- Vein of Galen Malformation: another pediatric arteriovenous shunt lesion.
- Hereditary Vasculopathies: HHT and other syndromic AVMs.
- Epilepsy Surgery in Children: Overview: AVM-related seizures.
- Spinal and Spinal Cord AVMs and AV Fistulas in Children: the spinal counterpart.
- Craniotomy for Arteriovenous Malformation: step-by-step procedure.
References
- Garcia JH, Rutledge C, Winkler EA, et al. Validation of the Ruptured Arteriovenous Malformation Grading Scale in a pediatric cohort. J Neurosurg Pediatr 2022;29(5):575–579. doi:10.3171/2022.1.PEDS21466. PMID 35213838. verified
- Nikolaev SI, Vetiska S, Bonilla X, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 2018;378(3):250–261. doi:10.1056/NEJMoa1709449. PMID 29298116. verified
- de Oliveira Manduca Palmiero H, Gadelha Figueiredo E. Management of pediatric brain arteriovenous malformation: a systematic review of retrospective studies. Neurosurg Rev 2026;49(1):424. doi:10.1007/s10143-026-04346-2. PMID 42204010. verified
- Winkler EA, Lu A, Morshed RA, et al. Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children. J Neurosurg Pediatr 2020;26(1):82–91. doi:10.3171/2020.1.PEDS19487. PMID 32276243. verified
- Pepper J, Lamin S, Thomas A, et al. Clinical features and outcome in pediatric arteriovenous malformation: institutional multimodality treatment. Childs Nerv Syst 2023;39(4):975–982. doi:10.1007/s00381-022-05800-4. PMID 36580118. verified
- Lu AY, Winkler EA, Garcia JH, et al. A comparison of incidental and symptomatic unruptured brain arteriovenous malformations in children. J Neurosurg Pediatr 2023;31(5):463–468. doi:10.3171/2023.1.PEDS22541. PMID 36805316. verified
- Fullerton HJ, Achrol AS, Johnston SC, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 2005;36(10):2099–2104. doi:10.1161/01.STR.0000181746.77149.2b. PMID 16141419. verified
- Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383(9917):614–621. doi:10.1016/S0140-6736(13)62302-862302-8). PMID 24268105. verified
- Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65(4):476–483. doi:10.3171/jns.1986.65.4.0476. PMID 3760956. verified
- Lawton MT, Kim H, McCulloch CE, et al. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery 2010;66(4):702–713. doi:10.1227/01.NEU.0000367555.16733.E1. PMID 20190666. verified
- Thrash GW, Evans RE, Sun Y, et al. Stereotactic radiosurgery treatment of pediatric arteriovenous malformations: a PRISMA systematic review and meta-analysis. Childs Nerv Syst 2025;41(1):188. doi:10.1007/s00381-025-06835-z. PMID 40407914. verified
- Burke RM, Chen CJ, Ding D, et al. Early obliteration of pediatric brain arteriovenous malformations after stereotactic radiosurgery: an international multicenter study. J Neurosurg Pediatr 2020;26(4):398–405. doi:10.3171/2020.4.PEDS19738. PMID 32590353. verified
- Calafiore R, Burke RM, Becerril-Gaitan A, et al. Characterization of pediatric infratentorial arteriovenous malformations: a retrospective, multicenter cohort study. Neurosurgery 2024;95(5):1064–1071. doi:10.1227/neu.0000000000002977. PMID 38700839. verified
- Shinya Y, Tos SM, Hajikarimloo B, et al. Efficacy and safety profile of volume-staged stereotactic radiosurgery for ruptured, large pediatric arteriovenous malformations: a multicenter cohort analysis. J Neurosurg Pediatr 2026;38(3):385–394. doi:10.3171/2026.1.PEDS25593. PMID 42284606. verified
- Hak JF, Boulouis G, Kerleroux B, et al. Pediatric brain arteriovenous malformation recurrence: a cohort study, systematic review and meta-analysis. J Neurointerv Surg 2022;14(6):611–617. doi:10.1136/neurintsurg-2021-017777. PMID 34583986. verified
- Jimenez JE, Gersey ZC, Wagner J, et al. Role of follow-up imaging after resection of brain arteriovenous malformations in pediatric patients: a systematic review of the literature. J Neurosurg Pediatr 2017;19(2):149–156. doi:10.3171/2016.9.PEDS16235. PMID 27911246. verified
- Oushy S, Gilder HE, Nesvick CL, et al. Delayed recurrence of pediatric arteriovenous malformations after radiologically confirmed obliteration. J Neurosurg Pediatr 2022;30(2):195–202. doi:10.3171/2022.4.PEDS21471. PMID 35623369. verified
Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. The Spetzler–Martin point values (size under 3, 3–6 and over 6 cm; eloquence; deep drainage) are the standard scheme but are not stated in reference 9's abstract, so they are given as standard teaching. The direction of the supplementary-grade age and hemorrhage points is inferred from the factors listed in reference 10's abstract. References 7 (mixed ages) and 8–10 (adults or mixed) are not pediatric-only. The "about 60–80%" hemorrhagic presentation range is this text's synthesis of references 4 and 5. Vein of Galen malformations are covered in their own topic. The schematic is an original figure.